Characterization of Cell Biological and Physiological Functions of the Phosphoglycolate Phosphatase AUM

Total Page:16

File Type:pdf, Size:1020Kb

Characterization of Cell Biological and Physiological Functions of the Phosphoglycolate Phosphatase AUM Characterization of cell biological and physiological functions of the phosphoglycolate phosphatase AUM Charakterisierung zellbiologischer und physiologischer Funktionen der Phosphoglykolat-Phosphatase AUM Dissertation for a doctoral degree at the Graduate School of Life Sciences, Julius-Maximilians-Universität Würzburg (Section Biomedicine) submitted by Gabriela Segerer from Kitzingen am Main Würzburg, November 2015 Submitted on: ……………………………………………………………… Members of the Promotionskomitee : Chairperson: Prof. Dr. Manfred Gessler Primary Supervisor: Prof. Dr. Antje Gohla Supervisor (Second): Prof. Dr. Dr. Manfred Schartl Supervisor (Third): PD Dr. Heike Hermanns Date of Public Defence: …………………………………………… Date of Receipt of Certificates: …………………………………………. Table of contents Table of contents 1 INTRODUCTION 1 1.1 Phospho-regulation by kinases and phosphatases 1 1.2 Classification of phosphatases 2 1.3 Haloacid dehalogenase (HAD) phosphatases 3 1.3.1 Structural features of HAD phosphatases 3 1.3.2 HAD phosphatases in health and diseases 5 1.4 Characterization of phosphoglycolate phosphatase PGP 6 1.4.1 PGP dephosphorylates phosphoglycolate in vitro 7 1.4.1.1 Source of mammalian phosphoglycolate (PG) 7 1.4.1.2 Function of mammalian phosphoglycolate (PG) 8 1.4.1.3 TPI controls a branch point between glucose- and lipid metabolism 10 1.4.2 PGP acts as a tyrosine-directed phosphatase in vitro 11 1.4.3 PGP is a regulator of integrin-dependent cell adhesion 13 1.5 Integrins 14 1.5.1 Integrin signaling 15 1.5.2 Integrin-dependent cell adhesion, spreading and migration 16 1.6 Cytoskeletal rearrangements during cell adhesion and migration 17 1.6.1 Regulation of actin remodeling 19 1.6.2 Actin-based membrane structures 19 1.6.3 Circular dorsal ruffles (CDRs) 21 1.6.3.1 Functions of CDRs 21 1.6.3.2 CDR formation signaling 22 1.7 Role of PGP in vivo 23 2 AIM OF THE STUDY 25 3 MATERIALS AND METHODS 27 3.1 Materials 27 3.1.1 Chemicals and reagents 27 3.1.2 Technical equipment 30 3.1.3 Consumable supplies 30 I Table of contents 3.1.4 DNA- and protein ladders 31 3.1.5 Commercial kits 31 3.1.6 Commercial buffers 32 3.1.7 Cell lines and mouse models 32 3.1.8 Cell culture medium 32 3.1.9 Antibodies 33 3.1.10 Immunocytochemistry reagents 34 3.1.11 Pharmacological inhibitors and negative controls 34 3.1.12 Inhibitors for metabolic studies 35 3.1.13 Enzymes and purified proteins 35 3.1.14 Radioactive nucleotides 35 3.1.15 Plasmids 35 3.1.16 Solutions and buffers 36 3.1.17 Software 41 3.2 Methods 43 3.2.1 Generation and breeding of Pgp knockout PGP D34N knockin mice 43 3.2.2 Genotyping of mice 43 3.2.3 Agarose gel electrophoresis 44 3.2.4 Embryo explants and isolation of primary cells 44 3.2.5 Cell culture techniques 46 3.2.5.1 Cell lines, primary cells and cell culture 46 3.2.5.2 Freezing cells 47 3.2.5.3 Thawing cells 47 3.2.5.4 Transfection 47 3.2.5.5 Coating of cell culture dishes, endothelial cell sorting and lymphocyte activation 48 3.2.5.6 Immunocytochemistry 49 3.2.6 Cellular assays 49 3.2.6.1 Pharmacological inhibitors 49 3.2.6.2 Proliferation assays 49 3.2.6.3 Quantification of circular dorsal ruffles (CDR) 49 3.2.6.4 Cell spreading assays 50 3.2.6.5 PGP-rescue experiments 50 3.2.6.6 Endothelial cell spreading assays 51 3.2.6.7 Time lapse cell migration assays 51 3.2.6.8 Transwell cell migration assays 51 3.2.6.9 PKC activity assay 52 II Table of contents 3.2.6.10 Flow cytometry 53 3.2.7 Metabolic studies 53 3.2.7.1 Determination of glycerol 3-phosphate (G3P) levels 53 3.2.7.2 Lipidomics 53 3.2.7.3 Determination of ATP levels 54 3.2.7.4 Analysis of triose phosphate isomerase (TPI) activity 54 3.2.7.5 Analysis of cellular respiration 55 3.2.8 Protein analytics 56 3.2.8.1 Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) 56 3.2.8.2 Western Blot analysis 56 3.2.8.3 Immunoblot stripping 57 3.2.8.4 Preparation of cell lysates 57 3.2.8.5 Immunoprecipitation 57 3.2.9 Experiments with purified proteins 58 3.2.9.1 Cellular PLC γ1 dephosphorylation assays 58 3.2.9.2 Recombinant PLC γ1 dephosphorylation assays 59 3.2.10 Image quantification 59 3.2.11 Statistical analysis 59 4 RESULTS 61 4.1 Role of phosphoglycolate phosphatase (PGP) for cell spreading and cell migration 61 4.1.1 Cellular effects of PGP 62 4.1.1.1 PGP activity regulates integrin- and RTK- induced circular dorsal ruffle formation 62 4.1.1.2 PGP localizes to circular dorsal ruffles 66 4.1.1.3 PGP regulates integrin- and RTK-induced cell spreading in a CDR- dependent manner 67 4.1.1.4 Loss of PGP activity increases cell spreading of mouse lung endothelial cells 70 4.1.1.5 PGP regulates cell migration 72 4.1.1.6 PGP inactivation in lymphocytes lead to an increase in cell migration 74 4.1.2 Molecular mechanisms of PGP-dependent effects on CDR formation, cell spreading and cell migration 76 4.1.2.1 Role of PGP in EGF-receptor signaling 77 4.1.2.2 PGP regulates CDR–formation and cell migration by modulating PLC γ1 activity downstream of Src kinase family signaling 80 4.1.2.3 Decrease in PLC γ1 activity leads to a reduction of PKC-mediated effects 84 III Table of contents 4.1.2.4 Loss of PGP catalyzes PKC-mediated effects on cytoskeleton 86 4.1.2.5 PLC γ1 is not a direct protein substrate of PGP 88 4.1.2.6 PGP inactivation leads to altered membrane composition 90 4.2 The role of phosphoglycolate phosphatase in vivo 93 4.2.1 Whole-body PGP inactivation (EIIa-mouse) is embryonic lethal 93 4.2.2 Deletion of PGP activity in endothelial and hematopoietic cells 96 4.2.3 Effects of whole-body PGP inactivation on the cardiovascular system 96 4.2.4 Loss of PGP activity causes an oxygen-dependent proliferation defect 97 4.2.5 Loss of PGP activity leads to a metabolic shift towards increased lipogenesis 100 4.2.6 PGP loss elevates energy-producing metabolism in an oxygen-dependent manner 106 5 DISCUSSION 113 5.1 Role of PGP for cell spreading and cell migration 114 5.1.1 Does PGP primarily act as a PG phosphatase and/or as a tyrosine-directed phosphatase during cell spreading and migration? 114 5.1.2 What is the link between upregulated PS levels and PGP-dependent effects on cell spreading and cell migration? 116 5.1.2.1 Functions of PS 116 5.1.2.2 PS accumulation leads to catalyzed PKC-mediated signal transduction 117 5.1.3 Untargeted lipidomic analysis of GC-1 cells 119 5.1.4 Inhibitor studies 120 5.1.5 Do elevated cellular ATP levels affect actin reorganization? 120 5.1.6 CDR formation 122 5.1.6.1 Signaling pathways involved in CDR formation 122 5.1.6.2 CDR functions 123 5.2 Physiological functions of PGP 125 5.2.1 PGP inactivation leads to cell proliferation arrest 125 5.2.2 Is PGP a PG phosphatase in vitro and in vivo? 126 5.2.3 Analysis of the link between DNA damage-derived PG and inhibition of TPI activity 127 5.2.4 Ablation of PGP activity only moderately inhibits TPI activity 127 5.2.5 Glycolysis, gluconeogenesis and glyceroneogenesis as potential PG-regulated processes 128 5.2.6 TPI inhibition results in the accumulation of long-chain polyunsaturated fatty acids 130 5.2.7 PG inactivation leads to elevated lipogenesis and lipolysis 131 IV Table of contents 6 SUMMARY 135 7 REFERENCES 141 8 APPENDIX 159 8.1 Curriculum vitae 159 8.2 Publication list and conference contributions 161 8.3 Affidavit 163 8.4 Acknowledgments 165 V VI Figure and table index Figure and table index Figure 1: Human phosphatome. ......................................................................................... 3 Figure 2: Structural diversity of HAD phosphatase cap domains. ................................... 4 Figure 3: PGP is a PG phosphatase in vitro . ..................................................................... 7 Figure 4: Origin of mammalian phosphoglycolate (PG). .................................................. 8 Figure 5: TPI inhibition by phosphoglycolate. .................................................................. 9 Figure 6: Carbohydrate- and lipid metabolism. ................................................................10 Figure 7: PGP is implicated in growth factor signaling. ..................................................11 Figure 8: Simplified model of EGF receptor signaling. ....................................................12 Figure 9: Role of PGP for cell adhesion. ...........................................................................14 Figure 10: Integrin activation signaling. ...........................................................................15 Figure 11: Actin dynamics and focal adhesion turnover during cell spreading and migration. ..........................................................................................................18 Figure 12: Protrusive actin structures. .............................................................................20 Figure 13: CDR formation signaling. .................................................................................23 Figure 14: Pgp targeting strategy. .....................................................................................24 Figure 15: Lymph node atlas. ............................................................................................45 Figure 16: Transwell assay based on the Boyden chamber method. .............................52 Figure 17: Mitochondrial stress assay. .............................................................................55 Figure 18: Western blot sandwich. ....................................................................................56 Figure 19: Spermatogonial GC1 cell line. .........................................................................61
Recommended publications
  • Identification of Potential Key Genes and Pathway Linked with Sporadic Creutzfeldt-Jakob Disease Based on Integrated Bioinformatics Analyses
    medRxiv preprint doi: https://doi.org/10.1101/2020.12.21.20248688; this version posted December 24, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Identification of potential key genes and pathway linked with sporadic Creutzfeldt-Jakob disease based on integrated bioinformatics analyses Basavaraj Vastrad1, Chanabasayya Vastrad*2 , Iranna Kotturshetti 1. Department of Biochemistry, Basaveshwar College of Pharmacy, Gadag, Karnataka 582103, India. 2. Biostatistics and Bioinformatics, Chanabasava Nilaya, Bharthinagar, Dharwad 580001, Karanataka, India. 3. Department of Ayurveda, Rajiv Gandhi Education Society`s Ayurvedic Medical College, Ron, Karnataka 562209, India. * Chanabasayya Vastrad [email protected] Ph: +919480073398 Chanabasava Nilaya, Bharthinagar, Dharwad 580001 , Karanataka, India NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice. medRxiv preprint doi: https://doi.org/10.1101/2020.12.21.20248688; this version posted December 24, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Abstract Sporadic Creutzfeldt-Jakob disease (sCJD) is neurodegenerative disease also called prion disease linked with poor prognosis. The aim of the current study was to illuminate the underlying molecular mechanisms of sCJD. The mRNA microarray dataset GSE124571 was downloaded from the Gene Expression Omnibus database. Differentially expressed genes (DEGs) were screened.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 9,689,046 B2 Mayall Et Al
    USOO9689046B2 (12) United States Patent (10) Patent No.: US 9,689,046 B2 Mayall et al. (45) Date of Patent: Jun. 27, 2017 (54) SYSTEM AND METHODS FOR THE FOREIGN PATENT DOCUMENTS DETECTION OF MULTIPLE CHEMICAL WO O125472 A1 4/2001 COMPOUNDS WO O169245 A2 9, 2001 (71) Applicants: Robert Matthew Mayall, Calgary (CA); Emily Candice Hicks, Calgary OTHER PUBLICATIONS (CA); Margaret Mary-Flora Bebeselea, A. et al., “Electrochemical Degradation and Determina Renaud-Young, Calgary (CA); David tion of 4-Nitrophenol Using Multiple Pulsed Amperometry at Christopher Lloyd, Calgary (CA); Lisa Graphite Based Electrodes', Chem. Bull. “Politehnica” Univ. Kara Oberding, Calgary (CA); Iain (Timisoara), vol. 53(67), 1-2, 2008. Fraser Scotney George, Calgary (CA) Ben-Yoav. H. et al., “A whole cell electrochemical biosensor for water genotoxicity bio-detection”. Electrochimica Acta, 2009, 54(25), 6113-6118. (72) Inventors: Robert Matthew Mayall, Calgary Biran, I. et al., “On-line monitoring of gene expression'. Microbi (CA); Emily Candice Hicks, Calgary ology (Reading, England), 1999, 145 (Pt 8), 2129-2133. (CA); Margaret Mary-Flora Da Silva, P.S. et al., “Electrochemical Behavior of Hydroquinone Renaud-Young, Calgary (CA); David and Catechol at a Silsesquioxane-Modified Carbon Paste Elec trode'. J. Braz. Chem. Soc., vol. 24, No. 4, 695-699, 2013. Christopher Lloyd, Calgary (CA); Lisa Enache, T. A. & Oliveira-Brett, A. M., "Phenol and Para-Substituted Kara Oberding, Calgary (CA); Iain Phenols Electrochemical Oxidation Pathways”, Journal of Fraser Scotney George, Calgary (CA) Electroanalytical Chemistry, 2011, 1-35. Etesami, M. et al., “Electrooxidation of hydroquinone on simply prepared Au-Pt bimetallic nanoparticles'. Science China, Chem (73) Assignee: FREDSENSE TECHNOLOGIES istry, vol.
    [Show full text]
  • Paraneoplastic Neurological and Muscular Syndromes
    Paraneoplastic neurological and muscular syndromes Short compendium Version 4.5, April 2016 By Finn E. Somnier, M.D., D.Sc. (Med.), copyright ® Department of Autoimmunology and Biomarkers, Statens Serum Institut, Copenhagen, Denmark 30/01/2016, Copyright, Finn E. Somnier, MD., D.S. (Med.) Table of contents PARANEOPLASTIC NEUROLOGICAL SYNDROMES .................................................... 4 DEFINITION, SPECIAL FEATURES, IMMUNE MECHANISMS ................................................................ 4 SHORT INTRODUCTION TO THE IMMUNE SYSTEM .................................................. 7 DIAGNOSTIC STRATEGY ..................................................................................................... 12 THERAPEUTIC CONSIDERATIONS .................................................................................. 18 SYNDROMES OF THE CENTRAL NERVOUS SYSTEM ................................................ 22 MORVAN’S FIBRILLARY CHOREA ................................................................................................ 22 PARANEOPLASTIC CEREBELLAR DEGENERATION (PCD) ...................................................... 24 Anti-Hu syndrome .................................................................................................................. 25 Anti-Yo syndrome ................................................................................................................... 26 Anti-CV2 / CRMP5 syndrome ............................................................................................
    [Show full text]
  • Disorders Affecting Vitamin B6 Metabolism
    Received: 8 October 2018 Accepted: 12 December 2018 DOI: 10.1002/jimd.12060 REVIEW Disorders affecting vitamin B6 metabolism Matthew P. Wilson1 | Barbara Plecko2 | Philippa B. Mills1 | Peter T. Clayton1 1Genetics and Genomic Medicine, UCL GOS Institute of Child Health, London, UK Abstract 0 2Department of Pediatrics and Adolescent Vitamin B6 is present in our diet in many forms, however, only pyridoxal 5 -phosphate Medicine, Division of General Pediatrics, (PLP) can function as a cofactor for enzymes. The intestine absorbs nonphosphorylated University Childrens' Hospital Graz, B vitamers, which are converted by specific enzymes to the active PLP form. The role Medical University Graz, Graz, Austria 6 of PLP is enabled by its reactive aldehyde group. Pathways reliant on PLP include Correspondence amino acid and neurotransmitter metabolism, folate and 1-carbon metabolism, protein Philippa B. Mills, Genetics and Genomic and polyamine synthesis, carbohydrate and lipid metabolism, mitochondrial function Medicine, UCL GOS Institute of Child Health, 30 Guilford Street, London WC1N and erythropoiesis. Besides the role of PLP as a cofactor B6 vitamers also play other 1EH, UK. cellular roles, for example, as antioxidants, modifying expression and action of steroid Email: [email protected] Communicating Editor: Slyvia Stockler- hormone receptors, affecting immune function, as chaperones and as an antagonist of Ipsiroglu Adenosine-5'-triphosphate (ATP) at P2 purinoceptors. Because of the vital role of PLP in neurotransmitter metabolism, particularly synthesis of the inhibitory transmitter Funding information γ Schweizerischer Nationalfonds zur -aminobutyric acid, it is not surprising that various inborn errors leading to PLP defi- Förderung der wissenschaftlichen Forschung ciency manifest as B6-responsive epilepsy, usually of early onset.
    [Show full text]
  • Supplementary Informations SI2. Supplementary Table 1
    Supplementary Informations SI2. Supplementary Table 1. M9, soil, and rhizosphere media composition. LB in Compound Name Exchange Reaction LB in soil LBin M9 rhizosphere H2O EX_cpd00001_e0 -15 -15 -10 O2 EX_cpd00007_e0 -15 -15 -10 Phosphate EX_cpd00009_e0 -15 -15 -10 CO2 EX_cpd00011_e0 -15 -15 0 Ammonia EX_cpd00013_e0 -7.5 -7.5 -10 L-glutamate EX_cpd00023_e0 0 -0.0283302 0 D-glucose EX_cpd00027_e0 -0.61972444 -0.04098397 0 Mn2 EX_cpd00030_e0 -15 -15 -10 Glycine EX_cpd00033_e0 -0.0068175 -0.00693094 0 Zn2 EX_cpd00034_e0 -15 -15 -10 L-alanine EX_cpd00035_e0 -0.02780553 -0.00823049 0 Succinate EX_cpd00036_e0 -0.0056245 -0.12240603 0 L-lysine EX_cpd00039_e0 0 -10 0 L-aspartate EX_cpd00041_e0 0 -0.03205557 0 Sulfate EX_cpd00048_e0 -15 -15 -10 L-arginine EX_cpd00051_e0 -0.0068175 -0.00948672 0 L-serine EX_cpd00054_e0 0 -0.01004986 0 Cu2+ EX_cpd00058_e0 -15 -15 -10 Ca2+ EX_cpd00063_e0 -15 -100 -10 L-ornithine EX_cpd00064_e0 -0.0068175 -0.00831712 0 H+ EX_cpd00067_e0 -15 -15 -10 L-tyrosine EX_cpd00069_e0 -0.0068175 -0.00233919 0 Sucrose EX_cpd00076_e0 0 -0.02049199 0 L-cysteine EX_cpd00084_e0 -0.0068175 0 0 Cl- EX_cpd00099_e0 -15 -15 -10 Glycerol EX_cpd00100_e0 0 0 -10 Biotin EX_cpd00104_e0 -15 -15 0 D-ribose EX_cpd00105_e0 -0.01862144 0 0 L-leucine EX_cpd00107_e0 -0.03596182 -0.00303228 0 D-galactose EX_cpd00108_e0 -0.25290619 -0.18317325 0 L-histidine EX_cpd00119_e0 -0.0068175 -0.00506825 0 L-proline EX_cpd00129_e0 -0.01102953 0 0 L-malate EX_cpd00130_e0 -0.03649016 -0.79413596 0 D-mannose EX_cpd00138_e0 -0.2540567 -0.05436649 0 Co2 EX_cpd00149_e0
    [Show full text]
  • The Quest for Novel Extracellular Polymers Produced by Soil-Borne Bacteria
    Copyright is owned by the Author of the thesis. Permission is given for a copy to be downloaded by an individual for the purpose of research and private study only. The thesis may not be reproduced elsewhere without the permission of the Author. Bioprospecting: The quest for novel extracellular polymers produced by soil-borne bacteria A thesis presented in partial fulfilment of the requirements for the degree of Master of Science In Microbiology at Massey University, Palmerston North, New Zealand Jason Smith 2017 i Dedication This thesis is dedicated to my dad. Vaughan Peter Francis Smith 13 July 1955 – 27 April 2002 Though our time together was short you are never far from my mind nor my heart. ii Abstract Bacteria are ubiquitous in nature, and the surrounding environment. Bacterially produced extracellular polymers, and proteins are of particular value in the fields of medicine, food, science, and industry. Soil is an extremely rich source of bacteria with over 100 million per gram of soil, many of which produce extracellular polymers. Approximately 90% of soil-borne bacteria are yet to be cultured and classified. Here we employed an exploratory approach and culture based method for the isolation of soil-borne bacteria, and assessed their capability for extracellular polymer production. Bacteria that produced mucoid (of a mucous nature) colonies were selected for identification, imaging, and polymer production. Here we characterised three bacterial isolates that produced extracellular polymers, with a focus on one isolate that formed potentially novel proteinaceous cell surface appendages. These appendages have an unknown function, however, I suggest they may be important for bacterial communication, signalling, and nutrient transfer.
    [Show full text]
  • Effects of Vitamin B6 Metabolism on Oncogenesis, Tumor Progression and Therapeutic Responses
    Oncogene (2013) 32, 4995–5004 & 2013 Macmillan Publishers Limited All rights reserved 0950-9232/13 www.nature.com/onc REVIEW Effects of vitamin B6 metabolism on oncogenesis, tumor progression and therapeutic responses L Galluzzi1,2,8, E Vacchelli2,3,4, J Michels2,3,4, P Garcia2,3,4, O Kepp2,3,4, L Senovilla2,3,4, I Vitale2,3,4 and G Kroemer1,4,5,6,7,8 Pyridoxal-50-phosphate (PLP), the bioactive form of vitamin B6, reportedly functions as a prosthetic group for 44% of classified enzymatic activities of the cell. It is therefore not surprising that alterations of vitamin B6 metabolism have been associated with multiple human diseases. As a striking example, mutations in the gene coding for antiquitin, an evolutionary old aldehyde dehydrogenase, result in pyridoxine-dependent seizures, owing to the accumulation of a metabolic intermediate that inactivates PLP. In addition, PLP is required for the catabolism of homocysteine by transsulfuration. Hence, reduced circulating levels of B6 vitamers (including PLP as well as its major precursor pyridoxine) are frequently paralleled by hyperhomocysteinemia, a condition that has been associated with an increased risk for multiple cardiovascular diseases. During the past 30 years, an intense wave of clinical investigation has attempted to dissect the putative links between vitamin B6 and cancer. Thus, high circulating levels of vitamin B6, as such or as they reflected reduced amounts of circulating homocysteine, have been associated with improved disease outcome in patients bearing a wide range of hematological and solid neoplasms. More recently, the proficiency of vitamin B6 metabolism has been shown to modulate the adaptive response of tumor cells to a plethora of physical and chemical stress conditions.
    [Show full text]
  • Supplementary Figure 1. Pyridoxine Deficiency Has No Effects on Total
    Supplementary Figure 1. Pyridoxine deficiency has no effects on total exploratory activity in control and Pyr-def mice; data were analyzed with two-way ANOVA followed by Bonferroni post-tests (n = 7 per group). 1 Fig. 1. Pyridoxine deficiency (Pyr-def) decreases serum and brain PLP levels, novel object recognition memory, and monoamine levels in the hippocampus. (A) PLP concentration in serum and brain regions (cerebral cortex, hippocampus and thalamus); data are analyzed with the Student’s t-test (n = 20 per group; *p < 0.05). (B) Exploration time for familiar and new objects and the discrimination index in control and Pyr-def mice; data were analyzed with two-way ANOVA followed by Bonferroni post-tests (n = 7 per group; *p < 0.05, significant difference between familiar and new object, #p < 0.05, significant difference between control and pyr-def group) and Student’s t-test (n = 7 per group; *p < 0.05). (C) 5- Hydroxytryptamine (5-HT), its metabolite (5-HIAA), and ratio (5-HIAA/5-HT) in the hippocampus of control and Pyr-def mice measured with HPLC analysis (n = 7 mice per group; *P < 0.05). (D) Levels of 3,4-Dihydroxyphenethylamine (DA), 3,4-dihydroxyphenylacetic acid (DOPAC), homovanillic acid (HVA), and ratio (DOPAC/DA and HVA/DA) in the hippocampus of control and Pyr-def mice measured through HPLC analysis (n = 7 mice per group; *P < 0.05). 3.4. Effects of pyridoxine deficiency on Ki67 and DCX immunoreactivity In the control and Pyr-def groups, Ki67-positive proliferating cells were found in the subgranular zone of the dentate gyrus.
    [Show full text]
  • Investigating Vitamin B6-Dependent Epileptic Encephalopathies in Human Patients and a Mouse Model
    INVESTIGATING VITAMIN B6-DEPENDENT EPILEPTIC ENCEPHALOPATHIES IN HUMAN PATIENTS AND A MOUSE MODEL by Hilal Hamed Al Shekaili BSc, Sultan Qaboos University, 2008 MSc, Sultan Qaboos University, 2011 A THESIS SUBMITTED IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY in The Faculty of Graduate and Postdoctoral Studies (Medical Genetics) THE UNIVERSITY OF BRITISH COLUMBIA (Vancouver) August 2020 © Hilal Hamed Al Shekaili, 2020 The following individuals certify that they have read, and recommend to the Faculty of Graduate and Postdoctoral Studies for acceptance, the dissertation entitled: Investigating Vitamin B6-Dependent Epileptic Encephalopathies in Human Patients and a Mouse Model submitted by Hilal Al Shekaili in partial fulfilment of the requirements for the degree of Doctor of Philosophy in Medical Genetics Examining Committee: Dr. Jan M. Friedman, Department of Medical Genetics Supervisor Dr. Blair R. Leavitt, Department of Medical Genetics Co-supervisor Dr. Lorne Clarke, Department of Medical Genetics Supervisory Committee Member Dr. Sylvia Stockler, Department of Pediatrics University Examiner Dr. Daniel Goldowitz, Department of Medical Genetics University Examiner Additional Supervisory Committee Members: Dr. William T. Gibson, Department of Medical Genetics Supervisory Committee Member Dr. Clara van Karnebeek, Department of Pediatrics Supervisory Committee Member ii Abstract PLPHP deficiency is a recently discovered form of vitamin B6-dependent epilepsies (B6Es) that is caused by recessive mutations in PLPBP. PLPHP is involved in pyridoxal 5’-phosphate (PLP) homeostatic regulation. However, the mechanism by which PLPHP dysfunction disrupts PLP homeostasis and leads to the observed encephalopathy in patients was still elusive. We characterized the clinical, genomic and biochemical abnormalities in a new series of 12 PLPHP deficiency patients.
    [Show full text]
  • Purification and Characterization of Pyridoxine 5′-Phosphate
    Biosci. Biotechnol. Biochem., 69 (12), 2277–2284, 2005 Purification and Characterization of Pyridoxine 50-Phosphate Phosphatase from Sinorhizobium meliloti y Masaaki TAZOE, ,* Keiko ICHIKAWA,** and Tatsuo HOSHINO* Department of Applied Microbiology, Nippon Roche Research Center, Kamakura, Kanagawa 247-8530, Japan Received April 15, 2005; Accepted July 29, 2005 Here we report the purification and biochemical 1-deoxy-D-xylulose 5-phosphate. The former is synthe- characterization of a pyridoxine 50-phosphate phospha- sized from D-erythrose 4-phosphate in three reaction tase involved in the biosynthesis of pyridoxine in steps catalyzed by Epd, PdxB, and SerC (PdxF) proteins Sinorhizobium meliloti. The phosphatase was localized in that order.4–7) The latter is formed from pyruvate and in the cytoplasm and purified to electrophoretic homo- D-glyceraldehyde 3-phosphate by 1-deoxy-D-xylulose 5- geneity by a combination of EDTA/lysozyme treatment phosphate synthase (Dxs).8) The two intermediates are and five chromatography steps. Gel-filtration chroma- then combined by PdxA and PdxJ proteins to generate 0 tography with Sephacryl S-200 and SDS/PAGE dem- the first vitamin B6 compound: pyridoxine 5 -phosphate onstrated that the protein was a monomer with a (PNP).9) PNP is finally oxidized to the active form, PLP, molecular size of approximately 29 kDa. The protein by a PNP/PMP oxidase (PdxH).10) PLP and PMP are required divalent metal ions for pyridoxine 50-phos- easily interconverted by ubiquitous transaminases. phate phosphatase activity, and specifically catalyzed Sinorhizobium (formerly known as Rhizobium) meli- the removal of Pi from pyridoxine and pyridoxal 50- loti IFO 14782 produces large quantities of PN.11) Since phosphates at physiological pH (about 7.5).
    [Show full text]
  • Vitamin B-6 Metabolism and Interactions with TNAP Stephen P
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Opus: Research and Creativity at IPFW Indiana University - Purdue University Fort Wayne Opus: Research & Creativity at IPFW Chemistry Faculty Publications Department of Chemistry 2015 Vitamin B-6 Metabolism and Interactions with TNAP Stephen P. Coburn Indiana University - Purdue University Fort Wayne, [email protected] This research is a product of the Department of Chemistry faculty at Indiana University-Purdue University Fort Wayne. Follow this and additional works at: http://opus.ipfw.edu/chemistry_facpubs Part of the Biochemistry Commons, and the Chemistry Commons Opus Citation Stephen P. Coburn (2015). Vitamin B-6 Metabolism and Interactions with TNAP. Neuronal Tissue-Nonspecific Alkaline Phosphatase (TNAP). 207-238. London: Springer. http://opus.ipfw.edu/chemistry_facpubs/96 This Book Chapter is brought to you for free and open access by the Department of Chemistry at Opus: Research & Creativity at IPFW. It has been accepted for inclusion in Chemistry Faculty Publications by an authorized administrator of Opus: Research & Creativity at IPFW. For more information, please contact [email protected]. Chapter 11 Vitamin B-6 Metabolism and Interactions with TNAP Stephen P. Coburn Abstract Two observations stimulated the interest in vitamin B-6 and alkaline phosphatase in brain: the marked increase in plasma pyridoxal phosphate and the occurrence of pyridoxine responsive seizures in hypophosphatasia. The increase in plasma pyridoxal phosphate indicates the importance of tissue non-specific alkaline phosphatase (TNAP) in transferring vitamin B-6 into the tissues. Vitamin B-6 is involved in the biosynthesis of most of the neurotransmitters.
    [Show full text]
  • All Enzymes in BRENDA™ the Comprehensive Enzyme Information System
    All enzymes in BRENDA™ The Comprehensive Enzyme Information System http://www.brenda-enzymes.org/index.php4?page=information/all_enzymes.php4 1.1.1.1 alcohol dehydrogenase 1.1.1.B1 D-arabitol-phosphate dehydrogenase 1.1.1.2 alcohol dehydrogenase (NADP+) 1.1.1.B3 (S)-specific secondary alcohol dehydrogenase 1.1.1.3 homoserine dehydrogenase 1.1.1.B4 (R)-specific secondary alcohol dehydrogenase 1.1.1.4 (R,R)-butanediol dehydrogenase 1.1.1.5 acetoin dehydrogenase 1.1.1.B5 NADP-retinol dehydrogenase 1.1.1.6 glycerol dehydrogenase 1.1.1.7 propanediol-phosphate dehydrogenase 1.1.1.8 glycerol-3-phosphate dehydrogenase (NAD+) 1.1.1.9 D-xylulose reductase 1.1.1.10 L-xylulose reductase 1.1.1.11 D-arabinitol 4-dehydrogenase 1.1.1.12 L-arabinitol 4-dehydrogenase 1.1.1.13 L-arabinitol 2-dehydrogenase 1.1.1.14 L-iditol 2-dehydrogenase 1.1.1.15 D-iditol 2-dehydrogenase 1.1.1.16 galactitol 2-dehydrogenase 1.1.1.17 mannitol-1-phosphate 5-dehydrogenase 1.1.1.18 inositol 2-dehydrogenase 1.1.1.19 glucuronate reductase 1.1.1.20 glucuronolactone reductase 1.1.1.21 aldehyde reductase 1.1.1.22 UDP-glucose 6-dehydrogenase 1.1.1.23 histidinol dehydrogenase 1.1.1.24 quinate dehydrogenase 1.1.1.25 shikimate dehydrogenase 1.1.1.26 glyoxylate reductase 1.1.1.27 L-lactate dehydrogenase 1.1.1.28 D-lactate dehydrogenase 1.1.1.29 glycerate dehydrogenase 1.1.1.30 3-hydroxybutyrate dehydrogenase 1.1.1.31 3-hydroxyisobutyrate dehydrogenase 1.1.1.32 mevaldate reductase 1.1.1.33 mevaldate reductase (NADPH) 1.1.1.34 hydroxymethylglutaryl-CoA reductase (NADPH) 1.1.1.35 3-hydroxyacyl-CoA
    [Show full text]